Respiratory and Circulation

Respiratory and Circulation — scientific infographic poster

After digestion, the second great traditional use of Angelica archangelica in northern Europe was for the chest in winter — coughs, colds, congestion — and for what old herbals called a “cold and stagnant” circulation. Angelica was a winter herb in a place with a long, dark, damp winter, and the cordials and restoratives that carried it were made to be drunk between October and April.

This page is going to be less satisfying than the tradition suggests, and that is deliberate. There is no clinical trial of angelica for cough, for bronchitis, for congestion, or for any circulatory condition. Not a weak one, not a flawed one — none. What exists is a plausible chemical story about volatile terpenes, a centuries-old body of practice, and one genuinely interesting twist: the only human trials this plant has ever had landed on a completely different smooth-muscle organ, the bladder. That turn is worth following, because it says something useful about where angelica’s real pharmacology might live.

Table of Contents

  1. The Winter Herb of the North
  2. What “Expectorant” Means and Whether Angelica Can Do It
  3. Inside the Oil: α-Pinene, β-Phellandrene and the Terpene Case
  4. What Respiratory Research Actually Exists
  5. “Warming the Blood” — Examining a Traditional Claim
  6. Smooth Muscle Is the Through-Line — and the Bladder Trials
  7. Coumarins, Blood Thinners and What the Concern Really Is
  8. Steams, Syrups and Cordials: The Forms People Use
  9. Practical Use and Dosing
  10. When a Cough Is Not a Herb Problem
  11. The Honest Verdict
  12. Key Research Papers
  13. Connections

The Winter Herb of the North

Angelica’s geography explains its reputation. This is a plant of Iceland, Norway, Sweden, Finland, the Faroes, Greenland’s settled fringes, the Alps and the wet north of Britain — places where fresh green plants are scarce for half the year and respiratory illness is a winter constant. A tall, strongly aromatic, easily cultivated perennial that stores well as dried root was a genuinely valuable thing to have.

Its folk names carry the reputation. Icelandic hvönn was cultivated and legally protected; in Sami and Nordic tradition the stems were eaten and the roots kept. The archangel legend — an angel revealing the plant as a remedy during plague — attached to angelica precisely because it was already regarded as a protective, strengthening plant, not the other way round.

The traditional respiratory framing was consistent: angelica was warming, drying and expectorant. It was for the person with a wet, rattling, lingering winter cough, cold hands and a general lack of vitality — not for a dry, irritated, hot cough, which the same herbals sent elsewhere. Whatever one makes of the underlying theory, the practitioners were making distinctions, which is more than most modern supplement marketing does.

What “Expectorant” Means and Whether Angelica Can Do It

An expectorant is meant to make mucus easier to clear — either by increasing the watery secretion that thins it (a secretomotor effect) or by changing its physical properties so it moves better up the mucociliary escalator.

The pharmacological route attributed to aromatic plants is the “gastro-pulmonary reflex”: an irritant or aromatic substance in the stomach triggers vagal signalling that increases bronchial secretion. Volatile terpenes have a second route — they are absorbed and partly excreted through the lungs, so they physically arrive at the airway surface. This is not fringe reasoning. It is the accepted rationale for cineole (eucalyptol) and for standardised myrtle-oil preparations, both of which have actual randomised trials in bronchitis and sinusitis.

So the mechanism is real for the class. The problem is specificity. Angelica has never been tested this way. No trial of angelica root in acute bronchitis, in chronic cough, in the common cold or in COPD exists. Nor is there an animal model of mucociliary clearance using A. archangelica. The claim is an inference from chemical family membership, and inferences from chemical family membership are how a great deal of herbal misinformation gets started.

A further honest point: even the well-studied aromatic expectorants have modest effects. Cineole and myrtol shorten symptoms in acute bronchitis by a matter of days at best. If angelica works in the same way and to the same degree, the realistic outcome is “slightly more comfortable” — not “cured.”

Inside the Oil: α-Pinene, β-Phellandrene and the Terpene Case

Angelica root essential oil is overwhelmingly a monoterpene hydrocarbon oil. Published analyses vary substantially with origin, plant part, harvest time and distillation method — which is a real limitation on generalising from any single paper — but the recurring picture is:

What do monoterpenes do? In laboratory work, α-pinene shows anti-inflammatory activity in cell models, some antimicrobial activity, and effects on airway and gut smooth muscle. Finnish researchers have characterised Arctic angelica essential oil and supercritical CO2 extracts specifically, confirming the terpene-dominated profile and screening for biological activity.

Two cautions on reading that literature. First, essential oils are antimicrobial in a Petri dish at concentrations no living tissue will ever see — this is close to universal among aromatic plants and tells you very little. Second, a component study is not a product study: knowing that α-pinene does something at 100 µM in a cell line says nothing about a cup of root tea, which delivers a few milligrams of a complex mixture into a 70-kilogram person.

What Respiratory Research Actually Exists

Stated plainly, so nobody has to hunt for the caveat: there is no human respiratory research on Angelica archangelica. No randomised trials, no controlled cohort work, no open-label series of any quality. Searching PubMed for angelica and bronchitis, cough, asthma or COPD returns work on related genera and on isolated furanocoumarins, not on this plant as a respiratory medicine.

What does exist, at the compound level:

None of that adds up to a respiratory indication. A reasonable summary for a patient: angelica is a traditional winter remedy whose chemistry is consistent with the aromatic-expectorant class, and which has never been tested for the purpose. If you want a herbal respiratory option that has actually been through trials, look at cineole-standardised eucalyptus preparations, standardised myrtol, ivy leaf extract or Pelargonium sidoides — all of which have real, if modest, randomised evidence.

“Warming the Blood” — Examining a Traditional Claim

European herbals describe angelica as warming to the blood and useful where circulation is cold and sluggish: cold hands and feet, a chilled constitution, poor recovery from winter illness.

Two honest observations.

First, the language resembles Chinese “blood-moving” terminology, and that resemblance is coincidence. The European tradition around A. archangelica developed in Nordic and Alpine Europe from its own humoral framework, centuries before any meaningful transmission of Chinese medical theory westward. The Chinese tradition around Angelica sinensis — Dong Quai — developed independently on a different species. Neither borrowed from the other. Writers who present European angelica as “the Western Dong Quai” are inventing a lineage that does not exist, and the invention obscures a practical point: the two plants have different chemistry and different risks.

Second, “warming” is not a testable endpoint. A warming sensation after a hot, aromatic, often alcoholic preparation is real and easily explained — hot liquid, alcohol-induced cutaneous vasodilation, and the pungent-aromatic sensation itself. Whether angelica changes peripheral perfusion in any measurable way is unknown, because nobody has put a laser Doppler probe on anyone’s finger after a dose. It would be a straightforward study to run. It has not been run.

For genuine cold extremities, the differential matters more than the herb: Raynaud phenomenon, hypothyroidism, anaemia, peripheral arterial disease and beta-blocker side effects are all common, all detectable, and all better addressed than warmed over with a tincture.

Smooth Muscle Is the Through-Line — and the Bladder Trials

Here is the genuinely interesting part of this page.

The airway, the blood vessel, the gut wall and the bladder are all lined with smooth muscle. If angelica has a real pharmacological action at achievable doses, an effect on smooth-muscle tone would explain the traditional digestive, respiratory and circulatory claims at once. And smooth muscle is exactly where the plant’s only human trials went — not by design, but because an Icelandic company happened to develop a product from it.

The 2013 nocturia trial — a negative result, reported honestly

SagaPro is an A. archangelica leaf extract tablet, developed in Iceland and marketed for waking at night to urinate. In 2013 its developers ran a parallel-group, randomised, double-blind, placebo-controlled trial: 69 men aged 45 or over with at least two nightly voids, eight weeks of treatment, voiding diaries before and after.

The result was negative. Nocturnal voids, the nocturnal polyuria index and the nocturnal bladder capacity index all improved — in both arms — with no significant difference between SagaPro and placebo. The authors stated the conclusion without spin: the study did not show that SagaPro improved nocturia overall. A post-hoc subgroup with reduced nocturnal bladder capacity did better on active treatment, and they flagged it as warranting further study rather than as a finding.

That trial deserves credit for how it was written up, and it deserves to be quoted whenever someone cites SagaPro as proven.

The 2025 overactive-bladder pilot — a more encouraging result

A Spanish research group revisited the question with a registered, randomised, triple-blind, placebo-controlled pilot trial in 143 adults aged 18–75 with overactive bladder symptoms, using A. archangelica extract for six weeks and assessing outcomes with three-day voiding diaries and the International Prostate Symptom Score.

Compared with placebo, the supplemented group showed significant improvement in:

Nocturia improved only to a near-significant degree (p = 0.069) — consistent with the 2013 result. Total IPSS fell from 19.8 to 15.9 on active treatment versus 19.6 to 16.4 on placebo, a difference the authors describe as clinically meaningful but which is, in plain terms, small. Effect sizes were modest (generalised η² 0.03–0.12).

How much weight should this carry? It is a real registered trial with a decent sample size for a pilot, and it is the best human evidence angelica has. It is also self-described as preliminary, single-centre, and six weeks long, and it has not been independently replicated. Overactive bladder is a symptom-score condition with a substantial placebo response, which is why replication matters more than usual. Treat it as promising and unconfirmed.

What this means for the respiratory and circulatory claims

Not much, directly — a bladder result does not transfer to a bronchus. But it does two useful things. It shows the plant is capable of a measurable clinical effect on a smooth-muscle-dependent symptom, which makes the traditional antispasmodic framing more credible than pure folklore. And it shows how a real angelica trial looks, which is a useful yardstick against which to judge the claims that have never been tested.

Coumarins, Blood Thinners and What the Concern Really Is

Almost every source that mentions angelica and circulation repeats a version of: angelica contains coumarins, coumarins thin the blood, so avoid it with warfarin. The conclusion is reasonable. The reasoning is wrong, and the wrong reasoning has consequences.

Coumarin itself is not an anticoagulant. Simple coumarin is a fragrant compound found in tonka bean, sweet woodruff, sweet clover and cassia cinnamon, and it has no meaningful effect on clotting. The anticoagulant drug warfarin is a 4-hydroxycoumarin derivative — a chemically distinct compound that inhibits vitamin K epoxide reductase. The historical link runs through dicoumarol, which forms when sweet clover hay spoils and fungal action modifies the coumarin. Fresh plant coumarins do not do this.

Furanocoumarins are also not anticoagulants. Imperatorin, xanthotoxin, bergapten and angelicin are photosensitisers and enzyme inhibitors, not vitamin-K antagonists.

So why still be careful with warfarin? Because of the metabolic route rather than the pharmacodynamic one. Furanocoumarins are the compound class responsible for the grapefruit-juice drug interaction — bergamottin and 6′,7′-dihydroxybergamottin inhibit intestinal CYP3A4, raising blood levels of drugs that depend on it. Warfarin is metabolised largely by CYP2C9 with a CYP3A4 contribution to the less active isomer, and anything that perturbs the metabolism of a narrow-therapeutic-index anticoagulant is worth flagging. The interaction has not been demonstrated for angelica specifically; the concern is mechanistic plausibility, not measured effect.

Practical upshot: if you take warfarin, a DOAC, clopidogrel or another antiplatelet, tell your prescriber before adding concentrated angelica, and do not start it in the week before surgery. Not because the coumarins thin your blood — they do not — but because you should not casually add an enzyme-active botanical to a drug whose dose is titrated to a blood test. The full discussion is in the safety article.

Steams, Syrups and Cordials: The Forms People Use

Steam inhalation

A traditional and low-risk way to use an aromatic plant for congestion: a bowl of just-boiled water, a small amount of dried root or crushed seed, a towel over the head, five to ten minutes. Keep your face well clear of the water — scald injuries from inhalation bowls are common, particularly in children, and steam inhalation is not recommended for young children at all. Note that steam inhalation delivers the terpenes and largely leaves the heavy furanocoumarins behind, which makes it the gentler option.

Root or seed tea

1–2 g dried root, or half a teaspoon of crushed seed, per covered cup, steeped 10–15 minutes. Traditionally taken with a spoonful of honey for a winter cough. Honey is worth noting on its own account — it has better evidence for symptomatic cough relief in children over one year than most herbal preparations do. (Never honey under twelve months, because of infant botulism risk.)

Syrups and cordials

The traditional preparation for winter: root decocted, strained, and preserved with sugar or honey. Historically these were often alcoholic, which is worth remembering before recommending a nightly cordial to anyone.

The great liqueurs

Angelica root is a defining botanical in gin, Chartreuse, Bénédictine, many vermouths and Scandinavian aquavit. These are drinks, not remedies, and the alcohol dose in a “medicinal” digestif or winter cordial substantially exceeds any plausible herbal effect. Enjoy them as drinks.

Essential oil — not internally

Angelica root oil is a concentrated furanocoumarin source and a recognised phototoxic material. Do not swallow it, and do not apply it undiluted to skin that will see daylight.

Practical Use and Dosing

No evidence-based dose exists, because no dose-ranging trial exists. Traditional European practice:

And the fundamentals that outperform any herb for a winter cough: fluids, humidified air, sleep, stopping smoking, and a pillow or two for night-time cough. These are dull and they work.

When a Cough Is Not a Herb Problem

Get medical assessment rather than reaching for the tincture if there is:

Herbs are for the ordinary self-limiting winter cough. They are not for any of the above.

The Honest Verdict

Angelica’s respiratory and circulatory reputation is tradition without trials. The chemistry places it in the aromatic-expectorant family, whose better-studied members have modest real effects, so the idea is not unreasonable. But nobody has tested it, and a page that says so is more useful than one that borrows credibility from eucalyptus.

For a winter cough, angelica tea or a steam is a pleasant, low-risk comfort measure — and comfort measures are not nothing when you feel wretched. Expect comfort, not cure.

The circulation claim is weaker still: “warming” is a sensation, not an outcome, and cold extremities deserve a diagnosis rather than a tincture.

And the twist is worth carrying away. The one place Angelica archangelica has produced real human data is the bladder — one honest negative trial in 2013 and one encouraging unreplicated pilot in 2025. If you are going to try this plant on the strength of evidence rather than history, that is where the evidence is.

Key Research Papers

Each identifier below was verified live against NCBI E-utilities. Where no confirmed paper supports a claim — which for angelica and the respiratory tract means every claim — a topic search is linked instead of a citation.

The human trials (bladder — the only ones that exist)

  1. López-Seoane J, Gesteiro E, Castro-Alija MJ, Quesada-González C, Pérez-Ruiz M, González-Gross M. Effects of Angelica archangelica extract on overactive bladder: a pilot randomized controlled trial. Food Science & Nutrition. 2025;13(12):e71258. Positive on daytime voids, IPSS storage subscore and quality of life; nocturia only near-significant.
  2. Sigurdsson S, Geirsson G, Gudmundsdottir H, Egilsdottir PB, Gudbjarnason S. A parallel, randomized, double-blind, placebo-controlled study to investigate the effect of SagaPro on nocturia in men. Scandinavian Journal of Urology. 2013;47(1):26–32. Negative on the primary endpoint.
  3. Kowal NM, Eyjolfsson R, Olafsdottir ES. Investigations on the constituents of SagaPro tablets, a food supplement manufactured from Angelica archangelica leaf. Die Pharmazie. 2017;72(1):3–4. A sceptical analysis concluding the proposed active flavonoid is present at a dose unlikely to do anything.

Essential oil chemistry

  1. Korpinen RI, Välimaa AL, Liimatainen J, Kunnas S. Essential oils and supercritical CO2 extracts of Arctic angelica (Angelica archangelica L.), marsh Labrador tea and common tansy. Molecules. 2021;26(23).
  2. Fraternale D, Flamini G, Ricci D. Essential oil composition and antimicrobial activity of Angelica archangelica L. (Apiaceae) roots. Journal of Medicinal Food. 2014;17(9):1043–1047.
  3. Aćimović MG, Pavlović SĐ, Varga AO, et al. Chemical composition and antibacterial activity of Angelica archangelica root essential oil. Natural Product Communications. 2017;12(2):205–206.
  4. Lunz K, Stappen I. Back to the roots — an overview of the chemical composition and bioactivity of selected root-essential oils. Molecules. 2021;26(11).
  5. Sowndhararajan K, Deepa P, Kim M, Park SJ, Kim S. A review of the composition of the essential oils and biological activities of Angelica species. Scientia Pharmaceutica. 2017;85(3).

The blood-thinner question — the metabolic route

  1. Fuhr LM, Marok FZ, Fuhr U, Selzer D, Lehr T. Physiologically based pharmacokinetic modeling of bergamottin and 6,7-dihydroxybergamottin to describe CYP3A4-mediated grapefruit-drug interactions. Clinical Pharmacology & Therapeutics. 2023;114(2):470–482. The furanocoumarin–CYP3A4 mechanism, worked out in detail for the grapefruit case.
  2. Melough MM, Cho E, Chun OK. Furocoumarins: a review of biochemical activities, dietary sources and intake, and potential health risks. Food and Chemical Toxicology. 2018;113:99–107.

Compound-level work relevant to the respiratory claim

  1. Coumarins, including imperatorin, in animal models of asthma — a systematic review of the compound class rather than of angelica. Dos Santos IM, et al. Basic & Clinical Pharmacology & Toxicology. 2026;138(3):e70210.
  2. α-Pinene and monoterpene effects on airway and smooth muscle. PubMed search — no angelica-specific trial exists.
  3. Cineole and myrtol in acute bronchitis — the better-evidenced aromatic expectorants, for comparison. PubMed search.

Live PubMed Searches

  1. Angelica archangelica — everything
  2. Angelica and the respiratory tract
  3. SagaPro trials
  4. Herbal treatments for overactive bladder
  5. Placebo response in nocturia trials
  6. α-Pinene pharmacology
  7. β-Phellandrene
  8. Essential oils and mucociliary clearance
  9. Pelargonium sidoides in bronchitis
  10. Ivy leaf extract for cough
  11. Honey for cough in children
  12. Warfarin–herb interactions

Connections

Back to Table of Contents